Literature DB >> 11230372

Combination of hypercholesterolemia and hypertension augments renal function abnormalities.

M Rodriguez-Porcel1, J D Krier, A Lerman, P F Sheedy, J C Romero, C Napoli, L O Lerman.   

Abstract

Hypercholesterolemia and hypertension are both risk factors for end-stage renal disease. This study was designed to examine whether their coexistence augmented impairment in renal function and redox status. Regional renal hemodynamics and function in response to vasoactive challenges with acetylcholine or sodium nitroprusside were quantified by using electron-beam computed tomography in pigs after 12 weeks of either a normal (n=10) or hypercholesterolemic (n=10) diet, renovascular hypertension (n=7), or combined hypercholesterolemia+hypertension (n=6). The hypercholesterolemic and hypercholesterolemic+hypertensive groups had significantly increased serum cholesterol levels, whereas in the hypertensive and hypercholesterolemic+hypertensive groups, mean arterial pressure was significantly elevated compared with the group fed a normal diet. Basal regional renal perfusion and glomerular filtration rates were similar among the groups. In response to acetylcholine, cortical perfusion increased in normal animals (15.6+/-4.7%, P=0.002) but not in hypercholesterolemic or hypertensive animals (8.0+/-7.4% and 8.2+/-5.9%, respectively; P>0.05). Moreover, in the hypercholesterolemic+hypertensive group, cortical perfusion response was further attenuated (2.5+/-4.8%, P=0.02) and significantly different from the group fed a normal diet (P<0.05). The response to sodium nitroprusside followed a similar pattern, and the impairment was augmented in the hypercholesterolemic+hypertensive group. The functional abnormalities in hypercholesterolemia or hypertension were associated with a decrease in systemic and/or renal tissue levels of oxygen radical scavengers that was again accentuated in hypercholesterolemia+hypertension. These results demonstrate that concurrent hypercholesterolemia and hypertension have a greater detrimental effect on renal perfusion responses compared with hypercholesterolemia or hypertension alone, associated with a marked pro-oxidant shift in redox status. These effects may potentially augment renal functional impairment and play a role in the initiation and progression of renal injury in hypertension and atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11230372     DOI: 10.1161/01.hyp.37.2.774

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  13 in total

Review 1.  Small Vessels, Big Role: Renal Microcirculation and Progression of Renal Injury.

Authors:  Alejandro R Chade
Journal:  Hypertension       Date:  2017-02-13       Impact factor: 10.190

2.  Systemic biopolymer-delivered vascular endothelial growth factor promotes therapeutic angiogenesis in experimental renovascular disease.

Authors:  Alejandro R Chade; Maxx L Williams; Erika Guise; Luke J Vincent; Taylor W Harvey; Marija Kuna; Fakhri Mahdi; Gene L Bidwell
Journal:  Kidney Int       Date:  2017-12-19       Impact factor: 10.612

3.  Simvastatin decreases endothelial progenitor cell apoptosis in the kidney of hypertensive hypercholesterolemic pigs.

Authors:  Ronit Lavi; Xiang-Yang Zhu; Alejandro R Chade; Jing Lin; Amir Lerman; Lilach O Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-03-04       Impact factor: 8.311

Review 4.  Gained in translation: protective paradigms for the poststenotic kidney.

Authors:  Lilach O Lerman; Stephen C Textor
Journal:  Hypertension       Date:  2015-02-23       Impact factor: 10.190

5.  Hemodynamic determinants of perivascular collateral development in swine renal artery stenosis.

Authors:  James D Krier; John A Crane; Alfonso Eirin; Xiang-Yang Zhu; Amir Lerman; Lilach O Lerman
Journal:  Am J Hypertens       Date:  2012-12-13       Impact factor: 2.689

6.  Hypercholesterolemia Impairs Nonstenotic Kidney Outcomes After Reversal of Experimental Renovascular Hypertension.

Authors:  Dong Sun; Zhi Chen; Alfonso Eirin; Xiang-Yang Zhu; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Am J Hypertens       Date:  2016-01-05       Impact factor: 2.689

7.  Increased hypoxia and reduced renal tubular response to furosemide detected by BOLD magnetic resonance imaging in swine renovascular hypertension.

Authors:  Sabas I Gomez; Lizette Warner; John A Haas; Rodney J Bolterman; Stephen C Textor; Lilach O Lerman; Juan Carlos Romero
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-29

Review 8.  Angiogenesis in the kidney: a new therapeutic target?

Authors:  Lilach O Lerman; Alejandro R Chade
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-03       Impact factor: 2.894

9.  Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.

Authors:  Katherine R Tuttle; Lance D Dworkin; William Henrich; Barbara A Greco; Michael Steffes; Sheldon Tobe; Joseph I Shapiro; Kenneth Jamerson; Asya Lyass; Karol Pencina; Joseph M Massaro; Ralph B D'Agostino; Donald E Cutlip; Timothy P Murphy; Christopher J Cooper
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-25       Impact factor: 8.237

10.  A translational model of chronic kidney disease in swine.

Authors:  Alejandro R Chade; Maxx L Williams; Jason Engel; Erika Guise; Taylor W Harvey
Journal:  Am J Physiol Renal Physiol       Date:  2018-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.